-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Latest From Biotech Now
How to Drive International Innovation: Scientific American Worldview
Which countries are winning the innovation game? Will the U.S. maintain its leadership position in the future? Have emerging markets lived up to the hype? Which new partnerships are transforming industries? For the fifth year, Scientific American (SA) released their Worldview: A Global Biotechnology Perspective report at the 2013 BIO International Convention in Chicago. Included in this year’s report is the longest list of country rankings that SA has ever compiled and the numbers reveal Read More >
RFS Under Fire: History, Significance and Current Issues
Unquestionably, the federal Renewable Fuel Standard (RFS) is the most important policy affecting the U.S. biofuels industry. It supports the market for first-generation biofuels, creates the market for second-generation biofuels and it is vital to boosting the nation’s reliance on advanced biofuels from non-food-related feedstocks. This pivotal policy, however, has vocal opponents who have filed lawsuits against the Environmental Protection Agency (EPA), held Congressional hearings and formed stakeholder coalitions. On Wednesday, BIO ’ s International Convention featured Read More >
The Affordable Care Act is Here to Stay
The Patient Protection and Affordable Care Act (ACA) of 2010 includes provisions that could lead to new and improved treatments, cures and cost savings for patients. All of these changes, however, will impact the biotechnology industry and the future of patient access to needed medicines. In an expert panel at the 2013 BIO International Convention moderated by BioCentury’s Steve Usdin, multiple stakeholders addressed key elements of the ACA focused on both the value the ACA Read More >
Debt, Taxes and Politics: Is There a Way Out?
BIO President and CEO Jim Greenwood kicked off a keynote discussion with Sen. Alan Simpson and Erskine Bowles at the BIO International Convention, saying public policy can make or break the biotech industry’s best efforts to deliver innovations that make our world a better place, and then asked the esteemed duo if our government can make the tough choices needed to keep our economy strong. “You can’t tax your way out of this hole, you can’t cut spending your Read More >
Neal Carter on Ag Biotech: It’s Not An Experiment Anymore
BIO International Convention attendees filled the Food & Agriculture Pavilion on the Show Floor Wednesday to hear Dr. Neal Carter of Okanagan Specialty Fruits give a presentation he delivered at a TEDx event last October in Penticton, BC on the value of biotechnology in agriculture. Okanagan Specialty Fruits has developed a non-browning apple known as the Arctic Apple - just one of the many examples of ways biotechnology is improving agriculture. After spending many years as a farmer in Read More >
